Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant’s patents for its blockbuster MS drug Gilenya.
K&L Gates has bolstered its Australian intellectual property team by nabbing a leading IP lawyer and partner from rival Herbert Smith Freehills.
Westpac has been accused by the corporate regulator of insider trading before the $16 billion privatisation of electricity provider Ausgrid.
Costly add-on therapies sold by Monash IVF to thousands of women undergoing IVF — including pre-implantation genetic testing — are the targets of a new class action investigation.
The liquidators of Forge Group have won court approval to expand their insider trading case against construction company Clough over the $187 million sale of its stake in the failed engineering and construction firm.
NSW Deputy Premier John Barilaro is allegedly threatening to sue YouTuber Jordan Shanks for defamation over videos which allegedly implied he acted corruptly and engaged in a destructive campaign to make koalas extinct.
A former QC who is now a judge on the Victorian Supreme Court judge has been hit with costs following a ruling that he and a law firm acquired by Russell Kennedy provided negligent advice to a former client on a land purchase contract.
A judge weighing a $38.4 million settlement in a shareholder class action against aged care provider Estia Health has been told that two NSW Court of Appeal judgments barring class closure were “plainly wrong”, but in deciding whether to lock group members out of the settlement the judge says he won’t need to grapple with the landmark rulings.
A judge has shot down what he called a “risky” but novel proposal by 7-Eleven for a pre-trial ruling on sample objections to the relevance of evidence in two franchise class actions.
The former CEO of Australia Post has threatened to bring legal action over her departure if the Morrison government fails to enter mediation in the next two days.